Format

Send to

Choose Destination
See comment in PubMed Commons below
J Am Acad Dermatol. 2017 Jun;76(6):1206-1212. doi: 10.1016/j.jaad.2017.01.032. Epub 2017 Mar 30.

Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.

Author information

1
Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: john.barbieri@uphs.upenn.edu.
2
Department of Dermatology, Penn State Milton S. Hershey Medical Center, Hershey, Pennsylvania.
3
Yale University, New Haven, Connecticut; Department of Dermatology, Yale School of Medicine, New Haven, Connecticut.
4
Baylor College of Medicine, Houston, Texas.
5
Yale University, New Haven, Connecticut; Department of Public Health (Health Policy), Economics, and Management, Yale University, New Haven, Connecticut.
6
Department of Dermatology, University of Iowa (Carver) College of Medicine, Iowa City, Iowa.

Abstract

As the implementation of the Medicare Access and Children's Health Insurance Program Reauthorization Act begins, many dermatologists who provide Medicare Part B services will be subject to the reporting requirements of the Merit-based Incentive Payment System (MIPS). Clinicians subject to MIPS will receive a composite score based on performance across 4 categories: quality, advancing care information, improvement activities, and cost. Depending on their overall MIPS score, clinicians will be eligible for a positive or negative payment adjustment. Quality will replace the Physician Quality Reporting System and clinicians will report on 6 measures from a list of over 250 options. Advancing care information will replace meaningful use and will assess clinicians on activities related to integration of electronic health record technology into their practice. Improvement activities will require clinicians to attest to completion of activities focused on improvements in care coordination, beneficiary engagement, and patient safety. Finally, cost will be determined automatically from Medicare claims data. In this article, we will provide a detailed review of the Medicare Access and Children's Health Insurance Program Reauthorization Act with a focus on MIPS and briefly discuss the potential implications for dermatologists.

KEYWORDS:

Alternative Payment Model; Medicare Access and Children's Health Insurance Program Reauthorization Act; Merit-based Incentive Payment System; Sustainable Growth Rate; dermatology; health care reform; health policy; payment reform; small practices

PMID:
28365038
DOI:
10.1016/j.jaad.2017.01.032
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center